VEGFA and fibrosarcoma: Interestingly, the reduction of angiogenesis, tumor growth, and metastases following the administration of the anti-VEGF antibody [61,62,63,64] in a xenograft model of human fibrosarcoma HT1080 cell line was previously reported.